雜志介紹

Current Opinion In Pharmacology雜志介紹

《Current Opinion In Pharmacology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱當前藥理學觀點，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4，最新CiteScore 指數為8.8。

本刊近期中國學者發表的論文主要有：

• Metabolic crosstalk between thermogenic adipocyte and cancer cell: Dysfunction and therapeutics

  Author: Dong, Kai; Wei, Gang; Sun, Honglin; Gu, Di; Liu, Junli; Wang, Linhui

• Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries

  Author: He, MinKe; Liu, ShuYue; Lai, ZhiCheng; Du, ZeFeng; Li, QiJiong; Xu, Li; Kan, Anna; Shen, JianXian; Shi, Ming

• Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions

  Author: Maria C Pedroso de Lima

• Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease

  Author: Hongxing Lei

英文介紹

Current Opinion In Pharmacology雜志英文介紹

Current Opinion in Pharmacology (COPHAR) publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.